Relationship of striatal dopamine synthesis capacity to age and cognition

Journal of Neuroscience

Volumn 28, Issue 52, 2008, Pages 14320-14328

  Braskie, Meredith N ^a,b   Wilcox, Claire E ^a,c   Landau, Susan M ^a,b   O'Neil, James P ^b   Baker, Suzanne L ^b   Madison, Cindee M ^a   Kluth, Jennifer T ^a,b   Jagust, William J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aromatic amino acid decarboxylase; Basal ganglia; Caudate; Cognition; DOPA decarboxylase; FMT; Normal aging; PET; Prefrontal; Putamen; Striatum; Upregulation

Indexed keywords

DOPAMINE;

ADULT; AGED; AGING; ARTICLE; BRAIN DEVELOPMENT; CAUDATE NUCLEUS; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; FEMALE; FRONTAL LOBE; GROUPS BY AGE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROIMAGING; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN;

ADULT; AGED; AGED, 80 AND OVER; AGING; AROMATIC-L-AMINO-ACID DECARBOXYLASES; COGNITION; CORPUS STRIATUM; DIHYDROXYPHENYLALANINE; DOPAMINE; FEMALE; FLUORINE RADIOISOTOPES; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OXYGEN; POSITRON-EMISSION TOMOGRAPHY; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 58149373934     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3729-08.2008     Document Type: Article

References (114)

1. Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature. J Neural Transm 45:81-105.
2. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381.
3. Alfimova MV, Golimbet VE, Gritsenko IK, Lezheiko TV, Abramova LI, Strel'tsova MA, Khlopina IV, Ebstein R (2007) Interaction of dopamine system genes and cognitive functions in patients with schizophrenia and their relatives and in healthy subjects from the general population. Neurosci Behav Physiol 37:643-650.
4. 11C]-raclopride. Ann N Y Acad Sci 695:81-85.
5. Apud JA, Mattay V, Chen J, Kolachana BS, Callicott JH, Rasetti R, Alce G, Iudicello JE, Akbar N, Egan MF, Goldberg TE, Weinberger DR (2007) Tolcapone improves cognition and cortical information processing in normal human subjects. Neuropsychopharmacology 32:1011-1020.
6. Bäckman L, Ginovart N, Dixon RA, Wahlin TB, Wahlin A, Halldin C, Farde L (2000) Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am J Psychiatry 157:635-637.
7. Bennett CM, Baird AA (2006) Anatomical changes in the emerging adult brain: a voxel-based morphometry study. Hum Brain Mapp 27:766-777.
8. Benton AL, Hamsher KD (1989) Multilingual aphasia examination. Iowa City, IA: AJA Associates.
9. Bertolino A, Rubino V, Sambataro F, Blasi G, Latorre V, Fazio L, Caforio G, Petruzzella V, Kolachana B, Hariri A, Meyer-Lindenberg A, Nardini M, Weinberger DR, Scarabino T (2006) Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype. Biol Psychiatry 60:1250-1258.
10. Bhatt MH, Snow BJ, Martin WR, Pate BD, Ruth TJ, Calne DB (1991) Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow. Ann Neurol 29:673-677.
11. Blasi G, Mattay VS, Bertolino A, Elvevåg B, Callicott JH, Das S, Kolachana BS, Egan MF, Goldberg TE, Weinberger DR (2005) Effect of catechol-O-methyltransferase val158met genotype on attentional control. J Neurosci 25:5038-5045.
12. Cai JX, Arnsten AF (1997) Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 283:183-189.
13. Caldú X, Vendrell P, Bartrés-Faz D, Clemente I, Bargalló N, Jurado MA, Serra-Grabulosa JM, Junqué C (2007) Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 37:1437-1444.
14. Chéramy A, Romo R, Godeheu G, Baruch P, Glowinski J (1986) In vivo presynaptic control of dopamine release in the cat caudate nucleus - II. Facilitatory or inhibitory influence of L-glutamate. Neuroscience 19:1081-1090.
15. Clark CR, Paul RH, Williams LM, Arns M, Fallahpour K, Handmer C, Gordon E (2006) Standardized assessment of cognitive functioning during development and aging using an automated touchscreen battery. Arch Clin Neuropsychol 21:449-467.
16. Cohen RL, Sandler SP, Schroeder K (1987) Aging and memory for words and action events: effects of item repetition and list length. Psychol Aging 2:280-285.
17. Collier TJ, Lipton J, Daley BF, Palfi S, Chu Y, Sortwell C, Bakay RA, Sladek JR Jr, Kordower JH (2007) Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism. Neurobiol Dis 26:56-65.
18. Cools R, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M (2008) Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci 28:1208-1212.
19. Cordes M, Snow BJ, Cooper S, Schulzer M, Pate BD, Ruth TJ, Calne DB (1994) Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren. Ann Neurol 36:667-670.
20. Cruz-Muros I, Afonso-Oramas D, Abreu P, Barroso-Chinea P, Rodríguez M, González MC, Hernández TG (2007) Aging of the rat mesostriatal system: differences between the nigrostriatal and the mesolimbic compartments. Exp Neurol 204:147-161.
21. Daneman M, Carpenter PA (1980) Individual differences in working memory and reading. J Verbal Learn Verbal Behav 19:450-466.
22. DeJesus OT, Endres CJ, Shelton SE, Nickles RJ, Holden JE (1997) Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA. J Nucl Med 38:630-636.
23. DeJesus OT, Endres CJ, Shelton SE, Nickles RJ, Holden JE (2001) Noninvasive assessment of aromatic L-amino acid decarboxylase activity in aging rhesus monkey brain in vivo. Synapse 39:58-63.
24. DeJesus OT, Flores LG, Roberts AD, Dick DW, Bartlett RM, Murali D, Nickles RJ (2005) Aromatic L-amino acid decarboxylase (AAAD) activity in rhesus macaque striatum after MAO-Binhibition by Ro 16-6491. Synapse 56:54-56.
25. De Luca CR, Wood SJ, Anderson V, Buchanan JA, Proffitt TM, Mahony K, Pantelis C (2003) Normative data from the CANTAB. I: Development of executive function over the lifespan. J Clin Exp Neuropsychol 25:242-254.
26. Eberling JL, Roberts JA, Taylor SE, VanBrocklin HF, O'Neil JP, Nordahl TE (2002) No effect of age and estrogen on aromatic L-amino acid decarboxylase activity in rhesus monkey brain. Neurobiol Aging 23:479-483.
27. Eberling JL, Jagust WJ, Christine CW, Starr P, Larson P, Bankiewicz KS, Aminoff MJ (2008) Neurology 70:1980-1983.
28. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98:6917-6922.
29. 18F-dopa uptake: absence of an aging effect. J Cereb Blood Flow Metab 13:881-888.
30. Endres CJ, Swaminathan S, DeJesus OT, Sievert M, Ruoho AE, Murali D, Rommelfanger SG, Holden JE (1997) Affinities of dopamine analogs for monoamine granular and plasma membrane transporters: implications for PET dopamine studies. Life Sci 60:2399-2406.
31. Erixon-Lindroth N, Farde L, Wahlin TB, Sovago J, Halldin C, Bäckman L (2005) The role of the striatal dopamine transporter in cognitive aging. Psychiatry Res 138:1-12.
32. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
33. Fowler CJ, Wiberg A, Oreland L, Marcusson J, Winblad B (1980) The effect of age on the activity and molecular properties of human brain monoamine oxidase. J Neural Transm 49:1-20.
34. Gazzaley A, Cooney JW, Rissman J, D'Esposito M (2005) Top-down suppression deficit underlies working memory impairment in normal aging. Nat Neurosci 8:1298-1300.
35. Gibbs SE, D'Esposito M (2006) A functional magnetic resonance imaging study of the effects of pergolide, a dopamine receptor agonist, on component processes of working memory. Neuroscience 139:359-371.
36. 1 receptors in prefrontal cells and circuits. Brain Res Brain Res Rev 31:295-301.
37. Hadjiconstantinou M, Wemlinger TA, Sylvia CP, Hubble JP, Neff NH (1993) Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors. J Neurochem 60:2175-2180.
38. Harada N, Nishiyama S, Satoh K, Fukumoto D, Kakiuchi T, Tsukada H (2002) Age-related changes in the striatal dopaminergic system in the living brain: a multiparametric PET study in conscious monkeys. Synapse 45:38-45.
39. Haycock JW, Becker L, Ang L, Furukawa Y, Hornykiewicz O, Kish SJ (2003) Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. J Neurochem 87:574-585.
40. Heaton R (1993) Wisconsin Card Sorting Test manual: revised and expanded. Odessa, FL: Psychological Assessment Resources.
41. Hoffman EJ, Huang SC, Phelps ME (1979) Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr 3:299-308.
42. Ichise M, Ballinger JR, Tanaka F, Moscovitch M, St George-Hyslop PH, Raphael D, Freedman M (1998) Age-related changes in D2 receptor binding with iodine-123-iodobenzofuran SPECT. J Nucl Med 39:1511-1518.
43. Irwin I, DeLanney LE, McNeill T, Chan P, Forno LS, Murphy GM Jr, Di Monte DA, Sandy MS, Langston JW (1994) Aging and the nigrostriatal dopamine system: a non-human primate study. Neurodegeneration 3:251-265.
44. Ishikawa T, Dhawan V, Chaly T, Margouleff C, Robeson W, Dahl JR, Mandel F, Spetsieris P, Eidelberg D (1996a) Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease. J Nucl Med 37:216-222.
45. Ishikawa T, Dhawan V, Kazumata K, Chaly T, Mandel F, Neumeyer J, Margouleff C, Babchyck B, Zanzi I, Eidelberg D (1996b) Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/ PET. J Nucl Med 37:1760-1765.
46. 18F]fluoro-L-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates. Brain Res 750:264-276.
47. Kaasinen V, Vilkman H, Hietala J, Någren K, Helenius H, Olsson H, Farde L, Rinne J (2000) Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol Aging 21:683-688.
48. Kim ST, Choi JH, Kim D, Hwang O (2006) Increases in TH immunoreactivity, neuromelanin and degeneration in the substantia nigra of middle aged mice. Neurosci Lett 396:263-268.
49. Kish SJ, Zhong XH, Hornykiewicz O, Haycock JW (1995) Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies? Ann Neurol 38:260-264.
50. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158.
51. Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ (2008) Striatal dopamine and working memory. Cereb Cortex. Advance online publication. Retrieved December 2, 2008. doi:10.1093/cercor/bhn095
52. Lane HY, Liu YC, Huang CL, Hsieh CL, Chang YL, Chang L, Chang YC, Chang WH (2008) Prefrontal executive function and D(1), D(3), 5-HT(2A) and 5-HT(6) receptor gene variations in healthy adults. J Psychiatry Neurosci 33:47-53.
53. Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, Wudel J, Pal PK, de la Fuente-Fernandez R, Calne DB, Stoessl AJ (2000) In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 47:493-503.
54. Lloyd KG, Hornykiewicz O (1972) Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain. J Neurochem 19:1549-1559.
55. Luna B, Garver KE, Urban TA, Lazar NA, Sweeney JA (2004) Maturation of cognitive processes from late childhood to adulthood. Child Dev 75:1357-1372.
56. Martin WR, Palmer MR, Patlak CS, Calne DB (1989) Nigrostriatal function in humans studied with positron emission tomography. Ann Neurol 26:535-542.
57. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, Kolachana B, Callicott JH, Weinberger DR (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100:6186-6191.
58. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, Huang Y, Simpson N, Ngo K, Van Heertum R, Laruelle M (2001) Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21:1034-1057.
59. McGeer PL, McGeer EG (1976) Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea. J Neurochem 26:65-76.
60. Mehta MA, Swainson R, Ogilvie AD, Sahakian J, Robbins TW (2001) Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers. Psychopharmacology (Berl) 159:10-20.
61. Meltzer CC, Zubieta JK, Brandt J, Tune LE, Mayberg HS, Frost JJ (1996) Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 47:454-461.
62. Meltzer CC, Kinahan PE, Greer PJ, Nichols TE, Comtat C, Cantwell MN, Lin MP, Price JC (1999) Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med 40:2053-2065.
63. Mozley PD, Acton PD, Barraclough ED, Plössl K, Gur RC, Alavi A, Mathur A, Saffer J, Kung HF (1999) Effects of age on dopamine transporters in healthy humans. J Nucl Med 40:1812-1817.
64. 11C]DOPA. Life Sci 79:730-736.
65. 18F-FDG PET: measured metabolic abnormalities in schizophrenia are affected by cortical structural abnormalities. Neuroimage 31:1434-1444.
66. Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5:584-590.
67. Pohjalainen T, Rinne JO, Någren K, Syvälahti E, Hietala J (1998) Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Am J Psychiatry 155:768-773.
68. Pycock CJ, Kerwin RW, Carter CJ (1980) Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286:74-76.
69. Raz N, Torres IJ, Acker JD (1995) Age, gender, and hemispheric differences in human striatum: a quantitative review and new data from in vivo MRI morphometry. Neurobiol Learn Mem 63:133-142.
70. Reitan RM (1958) Validity of the Trailmaking Test as an indicator of organic brain damage. Percept Mot Skills 8:271-276.
71. Rinne JO, Lönnberg P, Marjamäki P (1990) Age-dependent decline in human brain dopamine D1 and D2 receptors. Brain Res 508:349-352.
72. 11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography. Neurology 50:152-156.
73. Roberts AC, De Salvia MA, Wilkinson LS, Collins P, Muir JL, Everitt BJ, Robbins TW (1994) 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J Neurosci 14:2531-2544.
74. Roesch-Ely D, Scheffel H, Weiland S, Schwaninger M, Hundemer HP, Kolter T, Weisbrod M (2005) Differential dopaminergic modulation of executive control in healthy subjects. Psychopharmacology (Berl) 178:420-430.
75. Rosin DL, Clark WA, Goldstein M, Roth RH, Deutch AY (1992) Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems. Neuroscience 48:831-839.
76. Roussos P, Giakoumaki SG, Pavlakis S, Bitsios P (2008) Planning, decision-making and the COMT rs4818 polymorphism in healthy males. Neuropsychologia 46:757-763.
77. Saura J, Andrés N, Andrade C, Ojuel J, Eriksson K, Mahy N (1997) Biphasic and region-specific MAO-B response to aging in normal human brain. Neurobiol Aging 18:497-507.
78. Sawle GV, Colebatch JG, Shah A, Brooks DJ, Marsden CD, Frackowiak RS (1990) Striatal function in normal aging: implications for Parkinson's disease. Ann Neurol 28:799-804.
79. Schemper M (1991) Non-parametric partial association revisited. Statistician 40:73-76.
80. Scherman D, Desnos C, Darchen F, Pollak P, Javoy-Agid F, Agid Y (1989) Striatal dopamine deficiency in Parkinson's disease: role of aging. Ann Neurol 26:551-557.
81. Seeman P, Bzowej NH, Guan HC, Bergeron C, Becker LE, Reynolds GP, Bird ED, Riederer P, Jellinger K, Watanabe S, Tourtellotte WW (1987) Human brain dopamine receptors in children and aging adults. Synapse 1:399-404.
82. Severson JA, Marcusson J, Winblad B, Finch CE (1982) Age-correlated loss of dopaminergic binding sites in human basal ganglia. J Neurochem 39:1623-1631.
83. Smith SM (1992) A new class of corner finder. Proceedings of the Third British Machine Vision Conference, Leeds, UK, January.
84. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143-155.
85. 18F-fluorodopa data. J Cereb Blood Flow Metab 22:232-239.
86. Sowell ER, Thompson PM, Holmes CJ, Jernigan TL, Toga AW (1999) In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat Neurosci 2:859-861.
87. Srinivasan K, Awapara J (1978) Substrate specificity and other properties of DOPA decarboxylase from guinea pig kidneys. Biochem Biophys Acta 526:597-604.
88. Starr JM, Fox H, Harris SE, Deary IJ, Whalley LJ (2007) COMT genotype and cognitive ability: a longitudinal aging study. Neurosci Lett 421:57-61.
89. Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643-662.
90. Suhara T, Fukuda H, Inoue O, Itoh T, Suzuki K, Yamasaki T, Tateno Y (1991) Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology (Berl) 103:41-45.
91. Tanna NK, Kohn MI, Horwich DN, Jolles PR, Zimmerman RA, Alves WM, Alavi A (1991) Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. Radiology 178:123-130.
92. Tunbridge EM, Weickert CS, Kleinman JE, Herman MM, Chen J, Kolachana BS, Harrison PJ, Weinberger DR (2007) Catechol-O-methyltransferase enzyme activity and protein expression in human prefrontal cortex across the postnatal lifespan. Cereb Cortex 17:1206-1212.
93. Tupala E, Hall H, Bergström K, Mantere T, Räsänen P, Särkioja T, Hiltunen J, Tiihonen J (2003) Different effect of age on dopamine transporters in the dorsal and ventral striatum of controls and alcoholics. Synapse 48:205-211.
94. 18F]FMT): efficient synthesis and comparison of radiolabeling. Appl Radiat Isot 61:1289-1294.
95. van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Zoghbi SS, Baldwin RM, Innis RB (2002) Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry 10:36-43.
96. Vernaleken I, Weibrich C, Siessmeier T, Buchholz HG, Rösch F, Heinz A, Cumming P, Stoeter P, Bartenstein P, Gründer G (2007a) Asymmetry in dopamine D(2/3) receptors of caudate nucleus is lost with age. Neuroimage 34:870-878.
97. 18F]-fluoro-L-DOPA-PET investigation. Hum Brain Mapp 28:931-939.
98. Vingerhoets FJ, Snow BJ, Schulzer M, Morrison S, Ruth TJ, Holden JE, Cooper S, Calne DB (1994) Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects. J Nucl Med 35:18-24.
99. 18F -N-methylspiroperidol. Psychiatry Res 67:11-16.
100. Wang Y, Chan GL, Holden JE, Dobko T, Mak E, Schulzer M, Huser JM, Snow BJ, Ruth TJ, Calne DB, Stoessl AJ (1998) Age-dependent decline of dopamine D1 receptors in human brain: a PET study. Synapse 30:56-61.
101. Watanabe H, Suda H, Sekihara S, Nomura Y (1987) D-1 type of dopamine autoreceptors are not involved in the regulation of dopamine synthesis in the striatum. Jpn J Pharmacol 43:327-330.
102. Wechsler D (1981) Wechsler Adult Intelligence Scale - revised. San Antonio, TX: The Psychological Corporation.
103. Wechsler D (1987) Wechsler Memory Scale - revised manual. San Antonio, TX: The Psychological Corporation.
104. Weickert CS, Webster MJ, Gondipalli P, Rothmond D, Fatula RJ, Herman MM, Kleinman JE, Akil M (2007) Postnatal alterations in dopaminergic markers in the human prefrontal cortex. Neuroscience 144:1109-1119.
105. Wenk GL, Pierce DJ, Struble RG, Price DL, Cork LC (1989) Age-related changes in multiple neurotransmitter systems in the monkey brain. Neurobiol Aging 10:11-19.
106. Westerink BH, de Vries JB (1989) On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci Lett 99:197-202.
107. Wolf ME, LeWitt PA, Bannon MJ, Dragovic LJ, Kapatos G (1991) Effect of aging on tyrosine hydroxylase protein content and the relative number of dopamine nerve terminals in human caudate. J Neurochem 56:1191-1200.
108. Yanase D, Matsunari I, Yajima K, Chen W, Fujikawa A, Nishimura S, Matsuda H, Yamada M (2005) Brain FDG PET study of normal aging in Japanese: effect of atrophy correction. Eur J Nucl Med Mol Imaging 32:794-805.
109. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37-49.
110. Zelnik N, Angel I, Paul SM, Kleinman JE (1986) Decreased density of human striatal dopamine uptake sites with age. Eur J Pharmacol 126:175-176.
111. Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20:45-57.
112. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, Lee ML, Xiao T, Papp A, Wang D, Sadée W (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A 104:20552-20557.
113. Zhu MY, Juorio AV, Paterson IA, Boulton AA (1992) Regulation of aromatic L-amino acid decarboxylase by dopamine receptors in the rat brain. J Neurochem 58:636-641.
114. Zhu MY, Juorio AV, Paterson IA, Boulton AA (1994) Regulation of aromatic L-amino acid decarboxylase in rat striatal synaptosomes: effects of dopamine receptor agonists and antagonists. Br J Pharmacol 112:23-30.